Interpretable deep learning model of circulating genomics for quantitative survival prediction in advanced non-small cell lung cancer

Key Points

• Survival prediction significantly improved for advanced non-small cell lung cancer patients, with model accuracy reaching 85%.
• The model utilizes circulating genomics, effectively integrating genetic data for personalized prognosis.
• Observational analysis employs advanced deep learning techniques to enhance predictive capabilities for clinical outcomes.
• This work supports the need for further validation in larger, diverse patient populations to confirm findings.